Based on the key measurements obtained from Onconetix's financial statements, Onconetix is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. At this time, Onconetix's Cash is very stable compared to the past year. As of the 17th of March 2025, Non Current Assets Total is likely to grow to about 98.6 M, while Other Current Liabilities is likely to drop about 1.5 M. Key indicators impacting Onconetix's financial strength include:
The essential information of the day-to-day investment outlook for Onconetix includes many different criteria found on its balance sheet. An individual investor should monitor Onconetix's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Onconetix.
Comparative valuation techniques use various fundamental indicators to help in determining Onconetix's current stock value. Our valuation model uses many indicators to compare Onconetix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Onconetix competition to find correlations between indicators driving Onconetix's intrinsic value. More Info.
Onconetix is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . At this time, Onconetix's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Onconetix's earnings, one of the primary drivers of an investment's value.
Onconetix Systematic Risk
Onconetix's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Onconetix volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Onconetix correlated with the market. If Beta is less than 0 Onconetix generally moves in the opposite direction as compared to the market. If Onconetix Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Onconetix is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Onconetix is generally in the same direction as the market. If Beta > 1 Onconetix moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Onconetix Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Onconetix's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Onconetix growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Onconetix help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Onconetix. We use our internally-developed statistical techniques to arrive at the intrinsic value of Onconetix based on widely used predictive technical indicators. In general, we focus on analyzing Onconetix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Onconetix's daily price indicators and compare them against related drivers.
When determining whether Onconetix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Onconetix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Onconetix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Onconetix Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Onconetix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Onconetix. If investors know Onconetix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Onconetix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(87.25)
Revenue Per Share
2.582
Return On Assets
(0.19)
Return On Equity
(2.01)
The market value of Onconetix is measured differently than its book value, which is the value of Onconetix that is recorded on the company's balance sheet. Investors also form their own opinion of Onconetix's value that differs from its market value or its book value, called intrinsic value, which is Onconetix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Onconetix's market value can be influenced by many factors that don't directly affect Onconetix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Onconetix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Onconetix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Onconetix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.